Cargando…
Viral Shedding in Mice following Intravenous Adenovirus Injection: Impact on Biosafety Classification
There have been numerous advances in gene therapy and oncolytic virotherapy in recent years, especially with respect to cutting-edge animal models to test these novel therapeutics. With all of these advances, it is important to understand the biosafety risks of testing these vectors in animals. We p...
Autores principales: | LaRocca, Christopher J., Jacobsen, Kari L., Inoko, Kazuho, Zakharkin, Stanislav O., Yamamoto, Masato, Davydova, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385405/ https://www.ncbi.nlm.nih.gov/pubmed/37515182 http://dx.doi.org/10.3390/v15071495 |
Ejemplares similares
-
Cancer imaging and therapy utilizing a novel NIS-expressing adenovirus: The role of adenovirus death protein deletion
por: Robertson, Matthew Glen, et al.
Publicado: (2021) -
Interferon‐expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model
por: Shinoda, Shuhei, et al.
Publicado: (2023) -
Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer
por: Salzwedel, Amanda O., et al.
Publicado: (2018) -
Showing the Way: Oncolytic Adenoviruses as Chaperones of Immunostimulatory Adjuncts
por: Huang, Jing Li, et al.
Publicado: (2016) -
CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer
por: Sato-Dahlman, Mizuho, et al.
Publicado: (2017)